1. Home
  2. NAMS vs FSM Comparison

NAMS vs FSM Comparison

Compare NAMS & FSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • FSM
  • Stock Information
  • Founded
  • NAMS 2019
  • FSM 1990
  • Country
  • NAMS Netherlands
  • FSM Canada
  • Employees
  • NAMS N/A
  • FSM N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • FSM Precious Metals
  • Sector
  • NAMS Health Care
  • FSM Basic Materials
  • Exchange
  • NAMS Nasdaq
  • FSM Nasdaq
  • Market Cap
  • NAMS 2.7B
  • FSM 2.3B
  • IPO Year
  • NAMS N/A
  • FSM N/A
  • Fundamental
  • Price
  • NAMS $27.00
  • FSM $7.68
  • Analyst Decision
  • NAMS Strong Buy
  • FSM Hold
  • Analyst Count
  • NAMS 10
  • FSM 1
  • Target Price
  • NAMS $41.40
  • FSM $8.00
  • AVG Volume (30 Days)
  • NAMS 872.1K
  • FSM 13.9M
  • Earning Date
  • NAMS 08-06-2025
  • FSM 11-05-2025
  • Dividend Yield
  • NAMS N/A
  • FSM N/A
  • EPS Growth
  • NAMS N/A
  • FSM 7355.92
  • EPS
  • NAMS N/A
  • FSM 0.50
  • Revenue
  • NAMS $64,006,000.00
  • FSM $1,187,211,000.00
  • Revenue This Year
  • NAMS N/A
  • FSM N/A
  • Revenue Next Year
  • NAMS N/A
  • FSM N/A
  • P/E Ratio
  • NAMS N/A
  • FSM $15.40
  • Revenue Growth
  • NAMS 762.15
  • FSM 46.81
  • 52 Week Low
  • NAMS $14.06
  • FSM $4.13
  • 52 Week High
  • NAMS $27.29
  • FSM $8.07
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 67.63
  • FSM 60.60
  • Support Level
  • NAMS $24.41
  • FSM $7.55
  • Resistance Level
  • NAMS $25.65
  • FSM $8.07
  • Average True Range (ATR)
  • NAMS 1.10
  • FSM 0.29
  • MACD
  • NAMS 0.05
  • FSM 0.02
  • Stochastic Oscillator
  • NAMS 98.63
  • FSM 66.53

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About FSM Fortuna Silver Mines Inc (Canada)

Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.

Share on Social Networks: